NEW YORK (GenomeWeb News) – Merck KGaA reported today that its Merck Millipore division had total revenues of €574 million ($795.9 million) for the third quarter.
Of that total, €314 million ($435.4 million) was attributable to Millipore, which had revenues of $412 million for the third quarter of 2009 as a stand-alone company.
The Merck Millipore division, known as EMD Millipore in the US and Canada, was formed after the German drug and chemicals giant acquired Millipore for around $7 billion this past summer. The division has three business units — Bioscience, Lab Solutions, and Process Solutions — and around 10,000 employees in 64 countries. The firms said at the time of the acquisition that Merck Millipore had pro forma revenues of roughly $2.9 billion in fiscal-year 2009.
According to Merck, all three business units within Merck Millipore had increased revenues, with sales in India and Japan rising significantly.
Merck's total revenues increased 25 percent year over year to €2.44 billion from €1.95 billion. Of that revenue growth, Millipore accounted for 16 percentage points, while currency translation provided around 5 percent growth.